SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "L773:1432 1041 OR L773:0031 6970 "

Search: L773:1432 1041 OR L773:0031 6970

  • Result 1-10 of 419
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Åstrand, Emelie, et al. (author)
  • Potential drug interactions during a three-decade study period : a cross-sectional study of a prescription register
  • 2007
  • In: European Journal of Clinical Pharmacology. - : Springer Science and Business Media LLC. - 0031-6970 .- 1432-1041. ; 63:9, s. 851-859
  • Journal article (peer-reviewed)abstract
    • Objectives  The increased risk of adverse events in patients receiving potentially interacting drugs has long been recognized. The purpose of the present study was to evaluate the change in the risk of receiving potentially interacting drugs during a period covering three decades and to examine the relative risk of actual drug combinations. Methods  The prescriptions from all individuals (about 8,000) with two or more prescriptions during three periods of 15 months, October to December 1983–1984, 1993–1994 and 2003–2004, were collected from an ongoing cohort study in the county of Jämtland, Sweden. The potential interactions were detected by a computerized system. Results  The relative risk (RR) of receiving potentially interacting drugs increased for type C interactions [RR: 1.177, 95% confidence interval (CI): 1.104–1.256] and decreased for type D interactions (RR: 0.714, 95% CI: 0.587–0.868) from the period 1983–1984 to 2003–2004. Polypharmacy for the participants increased by 61%, from 9.05 filled prescriptions per subject in 1983–1984 to 10.6 in 1993–1994 and 14.6 in 2003–2004. The RR was positively correlated to the pronounced increase in polypharmacy; in addition, an exponential relationship was found for the more severe type D interactions. Few interacting drug combinations were responsible for a large proportion of the risk. Conclusion  We conclude that the risk of receiving potentially interacting drugs was strongly correlated to the concomitant use of multiple drugs. The pronounced increase in polypharmacy over time implies a growing reason for prescribers and pharmacists to be aware of drug interactions. Recently established national prescription registers should be evaluated for drug interaction vigilance, both clinically and epidemiologically.
  •  
2.
  • Abulfathi, Ahmed A., et al. (author)
  • Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens
  • 2020
  • In: European Journal of Clinical Pharmacology. - : Springer Nature. - 0031-6970 .- 1432-1041. ; 76:11, s. 1557-1565
  • Journal article (peer-reviewed)abstract
    • Purpose Para-aminosalicylic acid (PAS) is currently one of the add-on group C medicines recommended by the World Health Organization for multidrug-resistant tuberculosis treatment. At the recommended doses (8-12 g per day in two to three divided doses) of the widely available slow-release PAS formulation, studies suggest PAS exposures are lower than those reached with older PAS salt formulations and do not generate bactericidal activity. Understanding the PASER dose-exposure-response relationship is crucial for dose optimization. The objective of our study was to establish a representative population pharmacokinetics model for PASER and evaluate the probability of bactericidal and bacteriostatic target attainment with different dosing regimens.Methods To this end, we validated and optimized a previously published population pharmacokinetic model on an extended dataset. The probability of target attainment was evaluated for once-daily doses of 12 g, 14 g, 16 g and 20 g PASER. Results The final optimized model included the addition of variability in bioavailability and allometric scaling with body weight on disposition parameters. Peak PAS concentrations over minimum inhibitory concentration of 100, which is required for bactericidal activity are achieved in 53%, 65%, 72% and 84% of patients administered 12, 14, 16 and 20 g once-daily PASER, respectively, when MIC is 1 mg/L. For the typical individual, the exposure remained above 1 mg/L for >= 98% of the dosing interval in all the evaluated PASER regimens.Conclusion The pharmacokinetic/pharmacodynamic parameters linked to bactericidal activity should be determined for 14 g, 16 g and 20 g once-daily doses of PASER.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 419
Type of publication
journal article (406)
conference paper (11)
research review (2)
Type of content
peer-reviewed (396)
other academic/artistic (23)
Author/Editor
Bertilsson, L (28)
Wallerstedt, Susanna ... (18)
Wettermark, B (17)
Gustafsson, LL (15)
Bergman, U (14)
Aklillu, E (12)
show more...
Gustafsson, Maria (11)
Dahl, ML (11)
Sjoqvist, F (11)
Merlo, Juan (10)
Eliasson, E (10)
Rane, A (10)
Höglund, Peter (9)
Melander, Arne (9)
Wettermark, Björn (8)
Mannheimer, B (8)
Hjemdahl, P (7)
Midlöv, Patrik (7)
Andersson, ML (7)
Dahl, Marja-Liisa (7)
Källén, Bengt (7)
Bottiger, Y (7)
Ashton, Michael, 195 ... (7)
Lindh, JD (7)
von Bahr, C (7)
Malmstrom, RE (6)
von Euler, Mia, 1967 ... (6)
Eriksson, Tommy (6)
Hasselstrom, J (6)
Lövheim, Hugo (6)
Mirghani, RA (5)
Andersen, M (5)
Ingelman-Sundberg, M (5)
Johnell, Kristina (5)
Tomson, G (5)
Pohanka, A (5)
Beck, O (5)
VITOLS, S (5)
Wadelius, Mia (5)
Svensson, JO (5)
Böttiger, Ylva (5)
Lindblad, Ulf (5)
Sandman, Per-Olof (5)
Ohlsson, Henrik (5)
Isaksson, Ulf (5)
Yasar, U (5)
Fastbom, J (5)
Fastbom, Johan (5)
Bondesson, Åsa ÅB (5)
Ulfvarson, J (5)
show less...
University
Karolinska Institutet (239)
Uppsala University (78)
Lund University (52)
University of Gothenburg (45)
Umeå University (35)
Linköping University (32)
show more...
Stockholm University (12)
Örebro University (9)
Royal Institute of Technology (6)
Linnaeus University (6)
Jönköping University (3)
University of Skövde (2)
Chalmers University of Technology (2)
University of Borås (2)
RISE (2)
Högskolan Dalarna (2)
Sophiahemmet University College (2)
Luleå University of Technology (1)
Karlstad University (1)
Swedish University of Agricultural Sciences (1)
show less...
Language
English (419)
Research subject (UKÄ/SCB)
Medical and Health Sciences (189)
Natural sciences (8)
Social Sciences (2)
Engineering and Technology (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view